Advertisement
Letter to the Editor|Articles in Press

Omicron proliferation in the nasal cavity may explain its high infectivity

  • Daisuke Tamura
    Correspondence
    Correspondence to: Department of Paediatrics, Jichi Medical University, 3311-1 Shimotsuke, Tochigi 329-0498, Japan.
    Affiliations
    Department of Pediatrics, Jichi Medical University, Tochigi, Japan
    Search for articles by this author
  • Yoshihiro Kawaoka
    Affiliations
    Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
    The University of Tokyo, Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), Tokyo 162-8655, Japan
    Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan
    Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA
    Search for articles by this author
Published:March 06, 2023DOI:https://doi.org/10.1016/j.jinf.2023.03.006
Omicron proliferation in the nasal cavity may explain its high infectivity
Previous ArticleInfection of wild rats with H5N6 subtype highly pathogenic avian influenza virus in China
Next ArticleSeverely ill COVID-19 patients have altered circulating levels of proteins controlling the epitranscriptome
      Dear Sir,
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Zheng J.
        • Wang Z.
        • Li J.
        • Zhang Y.
        • Jiang L.
        • Fu Y.
        • et al.
        High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection.
        J Infect. 2022; 84: e126-e128https://doi.org/10.1016/j.jinf.2022.02.015
        View in Article
        • Salvagno G.L.
        • Henry B.
        • Pighi L.
        • Nitto S.D.
        • Montagnana M.
        • Lippi G.
        SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load.
        J Infect. 2022; 84 (2022 Feb 26): 834-872https://doi.org/10.1016/j.jinf.2022.02.025.Epub
        View in Article
        • Marty F.M.
        • Chen K.
        • Verrill K.A.
        How to obtain a nasopharyngeal swab specimen.
        N Engl J Med. 2020; 382e76https://doi.org/10.1056/NEJMvcm2010260
        View in Article

      4. Centers for Disease Control and Prevention COVID-19. Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing. 〈https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html〉 [Accessed 25 February 2023].

        View in Article

      5. National Institute of Infectious Disease, Laboratory Manuals for Pathogen Detection. Manual for the detection of pathogen; 2019. nCoV. Ver. 2.6. 〈https://www.niid.go.jp/niid/images/epi/corona/2019-nCoVmanual20200217-en.pdf〉; 2020 [Accessed 25 February 2023].

        View in Article

      6. Thermo Fisher Scientific; TaqMan. SARS-CoV-2 mutation panel USER GUIDE. 〈https://assets.thermofisher.com/TFS-Assets/LSG/manuals/MAN0024768_TaqManSARS-CoV-2_MutationPanel_UG.pdf〉 [Accessed 25 February 2023].

        View in Article

      7. Centers for Disease Control and Prevention. COVID-19 isolation and precautions for people with COVID-19. 〈https://www.cdc.gov/coronavirus/2019-ncov/your-health/isolation.html〉 [Accessed 25 February 2023].

        View in Article

      8. World Health Organization. WHO updates COVID-19 guidelines on masks, treatments and patient care. 〈https://www.who.int/news/item/13-01-2023-who-updates-covid-19-guidelines-on-masks--treatments-and-patient-care〉 [Accessed 25 February 2023].

        View in Article

      9. Ministry of Health, Labor and Welfare. COVID-19 Q & A. 〈https://www.mhlw.go.jp/stf/covid-19/qa.html〉 [Accessed 25 February 2023].

        View in Article
        • Despres H.W.
        • Mills M.G.
        • Shirley D.J.
        • Schmidt M.M.
        • Huang M.L.
        • Roychoudhury P.
        • et al.
        Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer: RNA ratio for Delta and Epsilon vs. Alpha variants.
        Proc Natl Acad Sci USA. 2022; 119e2116518119https://doi.org/10.1073/pnas.2116518119
        View in Article

      Article info

      Publication history

      Published online: March 06, 2023
      Accepted: March 3, 2023

      Publication stage

      In Press Journal Pre-Proof

      Identification

      DOI: https://doi.org/10.1016/j.jinf.2023.03.006

      Copyright

      © 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX